ADMA BIOLOGICS, INC. Assets, Noncurrent
ADMA BIOLOGICS, INC. (ADMA) had Assets, Noncurrent of $29.56 thousand as of 2017-03-31, per its 10-Q filed 2017-05-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AssetsNoncurrent · last filed 2017-05-12
- 2017-03-31: Assets, Noncurrent $29.56K.
- 2016-12-31: Assets, Noncurrent $27.16K.
- 2016-09-30: Assets, Noncurrent $27.16K.
- 2016-06-30: Assets, Noncurrent $27.16K.
| Period end | Assets, Noncurrent | Assets, Noncurrent as first filed |
|---|---|---|
| 2017-03-31 | $29.56K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $27.16K 10-Q · filed 2017-05-12 | |
| 2016-09-30 | $27.16K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $27.16K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $30.72K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $27.16K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $65.05K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $45.16K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $207.78K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $94.80K 10-K · filed 2016-03-23 | $298.78K 10-K · filed 2015-03-09 |
| 2014-09-30 | $334.47K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $350.39K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $334.86K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $162.19K 10-K · filed 2015-03-09 | |
| 2013-09-30 | $746.84K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $667.67K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $710.00K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $827.98K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $439.54K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $439.54K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $349.54K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $770.62K 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |